Cesarean Section. Single delivery by caesarean section
Conditions
Interventions
Intervention 1: Intervention group: We inject for patients 2/5 milliliter rupivacaine (0/5 percent(12/5 milligram) Intrathecal plus 2/5 micro gram dexmedetomidin in 1/5 milliliter ( total volume 4 mil
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: 18-35 years ASA class I and II Patients undergoing cesarean section
Exclusion criteria
Exclusion criteria: Refusal of the patient to perform spinal anesthesia Failure to perform spinal anesthesia History of taking beta-blockers and alpha-2 agonists and calcium channel blockers Cardiovascular disease Coagulation disorders Localized infection in the spinal cord Topical infection in the history of allergy to dexmedmotidine and rupivacaine arrhythmia Psychological problems Fetal distress Peripheral and central neuropathy Symptoms for the onset of labor Hypertension Preeclampsia Restriction of intrauterine growth Contraindication of spinal anesthesia Polyhydramnios Macrosomia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Motor block. Timepoint: after start surgery. Method of measurement: bromeg scale.;Sensory block. Timepoint: after start surgery. Method of measurement: bromeg scale.;Pain. Timepoint: recovery and 2 hours after surgery. Method of measurement: Visual Analog Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Yazdi
Arak University of Medical Sciences
Outcome results
None listed